Polyphenol-Rich Wild Fruits of the Indian Himalayas as a Potential Nutraceutical Candidate for the Management of Endometriosis: A Review
Abstract
1. Introduction
2. Literature Search Methodology
3. Pathophysiology of Endometriosis
4. Prevalence of Endometriosis
5. Role of Oxidative Stress in the Progression of Endometriosis
6. Key Biomolecular Drivers in Endometriosis
6.1. Cyclooxygenase-2 (COX-2)
6.2. Inducible Nitric Oxide Synthase (iNOS)
6.3. Pro-Inflammatory Cytokines
6.4. Nuclear Factor-κB (NF-κB) Pathway
6.5. Matrix Metalloproteinases (MMPs)
6.6. Transforming Growth Factor β (TGF-β)
6.7. VEGF (Vascular Endothelial Growth Factor)
6.8. Estrogen Receptors
7. Most Researched Polyphenols in Mediating Symptoms of Endometriosis
7.1. Baicalein
7.2. Fisetin
7.3. Quercetin
7.4. Kaempferol
7.5. Myricetin
7.6. Epigallocatechin-3-Gallate
7.7. Apigenin
7.8. Luteolin
7.9. Resveratrol
7.10. Rutin
7.11. Anthocyanins
8. Clinical Trials on Polyphenols in Mediating Symptoms of Endometriosis
9. Overview of Biodiversity of Wild Fruits of the North Western Himalayas
10. Importance of Utilising Underutilized Plants in Traditional Medicine and Nutrition
10.1. Bioactive Potential of Underutilized Wild Edible Berries
10.1.1. Morus Species (M. nigra L. and M. alba L.)
10.1.2. Berberis asiatica
10.1.3. Duchesnea indica
10.1.4. Ficus palmata
10.1.5. Lycium barbarum
10.1.6. Myrica esculenta
10.1.7. Pyracantha crenulata
10.1.8. Rubus ellipticus
11. Challenges in Harnessing and Utilising Wild Fruits to Their Full Potential
12. Conclusions and Future Perspective
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Noce, A.; Marrone, G.; Parisi, A. Editorial: The impact of lifestyle changes on non-communicable diseases. Front. Nutr. 2024, 11, 1471019. [Google Scholar] [CrossRef]
- Cerf, M.E. Healthy lifestyles and noncommunicable diseases: Nutrition, the life-course, and health promotion. Lifestyle Med. 2021, 2, e31. [Google Scholar] [CrossRef]
- Sharifi-Rad, M.; Anil Kumar, N.V.; Zucca, P.; Varoni, E.M.; Dini, L.; Panzarini, E.; Rajkovic, J.; Tsouh Fokou, P.V.; Azzini, E.; Peluso, I.; et al. Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases. Front. Physiol. 2020, 11, 694. [Google Scholar] [CrossRef]
- Schieber, M.; Chandel, N.S. ROS function in redox signaling and oxidative stress. Curr. Biol. 2014, 24, R453–R462. [Google Scholar] [CrossRef] [PubMed]
- Costas, C.; Faro, L.R.F. Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson’s Disease. Curr. Neuropharmacol. 2022, 20, 432–459. [Google Scholar] [CrossRef] [PubMed]
- Galicia-Garcia, U.; Benito-Vicente, A.; Jebari, S.; Larrea-Sebal, A.; Siddiqi, H.; Uribe, K.B.; Ostolaza, H.; Martín, C. Pathophysiology of Type 2 Diabetes Mellitus. Int. J. Mol. Sci. 2020, 21, 6275. [Google Scholar] [CrossRef] [PubMed]
- Sharma, B.M.; Bharat, G.K.; Chakraborty, P.; Martiník, J.; Audy, O.; Kukučka, P.; Přibylová, P.; Kukreti, P.K.; Sharma, A.; Kalina, J.; et al. A comprehensive assessment of endocrine-disrupting chemicals in an Indian food basket: Levels, dietary intakes, and comparison with European data. Environ. Pollut. 2021, 288, 117750. [Google Scholar] [CrossRef]
- Lichtenstein, A.H.; Appel, L.J.; Vadiveloo, M.; Hu, F.B.; Kris-Etherton, P.M.; Rebholz, C.M.; Sacks, F.M.; Thorndike, A.N.; Van Horn, L.; Wylie-Rosett, J.; et al. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation 2021, 144, e472–e487. [Google Scholar] [CrossRef]
- Li, J.; Pandian, V.; Davidson, P.M.; Song, Y.; Chen, N.; Fong, D.Y.T. Burden and attributable risk factors of non-communicable diseases and subtypes in 204 countries and territories, 1990–2021: A systematic analysis for the global burden of disease study 2021. Int. J. Surg. 2025, 111, 2385–2397. [Google Scholar] [CrossRef]
- Haridoss, M.; Nandi, D.; Rajesh Lenin, R.; John, S.P.; Anantharaman, V.V.; Janardhanan, R. Health-seeking behavior and its determinants for non-communicable diseases in India—A systematic review and meta-analysis. Front. Public Health 2025, 13, 1580824. [Google Scholar] [CrossRef]
- Cena, H.; Calder, P.C. Defining a Healthy Diet: Evidence for The Role of Contemporary Dietary Patterns in Health and Disease. Nutrients 2020, 12, 334. [Google Scholar] [CrossRef]
- World Health Organization (WHO). Healthy Diet. Available online: https://www.who.int/news-room/fact-sheets/detail/healthy-diet (accessed on 5 March 2026).
- ‘Aqilah, N.M.N.; Rovina, K.; Felicia, W.X.L.; Vonnie, J.M. A Review on the Potential Bioactive Components in Fruits and Vegetable Wastes as Value-Added Products in the Food Industry. Molecules 2023, 28, 2631. [Google Scholar] [CrossRef] [PubMed]
- Saunders, P.T.K.; Horne, A.W. Endometriosis: Etiology, pathobiology, and therapeutic prospects. Cell 2021, 184, 2807–2824. [Google Scholar] [CrossRef]
- Taylor, H.S.; Kotlyar, A.M.; Flores, V.A. Endometriosis is a chronic systemic disease: Clinical challenges and novel innovations. Lancet 2021, 397, 839–852. [Google Scholar] [CrossRef] [PubMed]
- Zutautas, K.B.; Sisnett, D.J.; Miller, J.E.; Lingegowda, H.; Childs, T.; Bougie, O.; Lessey, B.A.; Tayade, C. The dysregulation of leukemia inhibitory factor and its implications for endometriosis pathophysiology. Front. Immunol. 2023, 14, 1089098. [Google Scholar] [CrossRef]
- Ahn, S.H.; Singh, V.; Tayade, C. Biomarkers in endometriosis: Challenges and opportunities. Fertil. Steril. 2017, 107, 523–532. [Google Scholar] [CrossRef] [PubMed]
- Chen, Q.; Wang, J.; Ding, X.; Zhang, Q.; Duan, P. Emerging strategies for the treatment of endometriosis. Biomed. Technol. 2024, 7, 46–62. [Google Scholar] [CrossRef]
- Gołąbek, A.; Kowalska, K.; Olejnik, A. Polyphenols as a Diet Therapy Concept for Endometriosis—Current Opinion and Future Perspectives. Nutrients 2021, 13, 1347. [Google Scholar] [CrossRef]
- Oală, I.E.; Mitranovici, M.-I.; Chiorean, D.M.; Irimia, T.; Crișan, A.I.; Melinte, I.M.; Cotruș, T.; Tudorache, V.; Moraru, L.; Moraru, R.; et al. Endometriosis and the Role of Pro-Inflammatory and Anti-Inflammatory Cytokines in Pathophysiology: A Narrative Review of the Literature. Diagnostics 2024, 14, 312. [Google Scholar] [CrossRef]
- Goleij, P.; Khandan, M.; Khazeei Tabari, M.A.; Sanaye, P.M.; Alijanzadeh, D.; Soltani, A.; Hosseini, Z.; Larsen, D.S.; Khan, H.; Kumar, A.P.; et al. Unlocking the Potential: How Flavonoids Affect Angiogenesis, Oxidative Stress, Inflammation, Proliferation, Invasion, and Alter Receptor Interactions in Endometriosis. Food Sci. Nutr. 2025, 13, e4607. [Google Scholar] [CrossRef]
- Osińska, D.; Woźniak, A.; Woźniak, S. The Role of Nutrition on the Pathogenesis of Endometriosis. Nutrients 2026, 18, 646. [Google Scholar] [CrossRef]
- Wani, S.K.; Ahmad, R.; Gulzar, R.; Rashid, I.; Malik, A.; Khuroo, A. Diversity, Distribution and Drivers of Alien Flora in the Indian Himalayan Region. Glob. Ecol. Conserv. 2022, 38, e02246. [Google Scholar] [CrossRef]
- Tripathi, A.K.; Pandey, P.C.; Sharma, J.K.; Triantakonstantis, D.; Srivastava, P.K. Climate Change and Its Impact on Forest of Indian Himalayan Region: A Review. In Climate Change: Impacts, Responses and Sustainability in the Indian Himalaya; Rani, S., Kumar, R., Eds.; Springer International Publishing: Cham, Switzerland, 2022; pp. 207–222. [Google Scholar]
- Pathak, R.; Pant, V.; Negi, V.S.; Bhatt, I.D.; Belwal, T. Introduction to Himalayan region and wild edible diversity. In Himalayan Fruits and Berries; Belwal, T., Bhatt, I., Devkota, H., Eds.; Academic Press: Cambridge, MA, USA, 2023; pp. 1–12. [Google Scholar]
- Ahn, S.H.; Monsanto, S.P.; Miller, C.; Singh, S.S.; Thomas, R.; Tayade, C. Pathophysiology and Immune Dysfunction in Endometriosis. Biomed. Res. Int. 2015, 2015, 795976. [Google Scholar] [CrossRef]
- Chen, L.-H.; Lo, W.-C.; Huang, H.-Y.; Wu, H.-M. A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment. Int. J. Mol. Sci. 2023, 24, 7503. [Google Scholar] [CrossRef] [PubMed]
- Ochoa Bernal, M.A.; Fazleabas, A.T. The Known, the Unknown and the Future of the Pathophysiology of Endometriosis. Int. J. Mol. Sci. 2024, 25, 5815. [Google Scholar] [CrossRef]
- Cousins, F.L.; McKinnon, B.D.; Mortlock, S.; Fitzgerald, H.C.; Zhang, C.; Montgomery, G.W.; Gargett, C.E. New concepts on the etiology of endometriosis. J. Obstet. Gynaecol. Res. 2023, 49, 1090–1105. [Google Scholar] [CrossRef] [PubMed]
- Adilbayeva, A.; Kunz, J. Pathogenesis of Endometriosis and Endometriosis-Associated Cancers. Int. J. Mol. Sci. 2024, 25, 7624. [Google Scholar] [CrossRef]
- Pašalić, E.; Tambuwala, M.M.; Hromić-Jahjefendić, A. Endometriosis: Classification, pathophysiology, and treatment options. Pathol. Res. Pract. 2023, 251, 154847. [Google Scholar] [CrossRef]
- Burney, R.O.; Giudice, L.C. Pathogenesis and pathophysiology of endometriosis. Fertil. Steril. 2012, 98, 511–519. [Google Scholar] [CrossRef]
- Scutiero, G.; Iannone, P.; Bernardi, G.; Bonaccorsi, G.; Spadaro, S.; Volta, C.A.; Greco, P.; Nappi, L. Oxidative Stress and Endometriosis: A Systematic Review of the Literature. Oxidative Med. Cell. Longev. 2017, 2017, 7265238. [Google Scholar] [CrossRef] [PubMed]
- Coperchini, F.; Greco, A.; Teliti, M.; Croce, L.; Chytiris, S.; Magri, F.; Gaetano, C.; Rotondi, M. Inflamm-ageing: How cytokines and nutrition shape the trajectory of ageing. Cytokine Growth Factor Rev. 2025, 82, 31–42. [Google Scholar] [CrossRef]
- Machairiotis, N.; Vasilakaki, S.; Thomakos, N. Inflammatory Mediators and Pain in Endometriosis: A Systematic Review. Biomedicines 2021, 9, 54. [Google Scholar] [CrossRef]
- World Health Organization (WHO). Endometeriosis. Available online: https://www.who.int/news-room/fact-sheets/detail/endometriosis (accessed on 26 December 2025).
- Shen, D.Y.; Li, J.; Hu, P.; Qi, C.; Yang, H. Global, regional, and national prevalence and disability-adjusted life-years for endometriosis in 204 countries and territories, 1990–2019: Findings from a global burden of disease study. Eur. J. Obstet. Gynecol. Reprod. Biol. X 2025, 25, 100363. [Google Scholar] [CrossRef]
- Aznaurova, Y.B.; Zhumataev, M.B.; Roberts, T.K.; Aliper, A.M.; Zhavoronkov, A.A. Molecular aspects of development and regulation of endometriosis. Reprod. Biol. Endocrinol. 2014, 12, 50. [Google Scholar] [CrossRef] [PubMed]
- Clower, L.; Fleshman, T.; Geldenhuys, W.J.; Santanam, N. Targeting Oxidative Stress Involved in Endometriosis and Its Pain. Biomolecules 2022, 12, 1055. [Google Scholar] [CrossRef]
- Orisaka, M.; Mizutani, T.; Miyazaki, Y.; Shirafuji, A.; Tamamura, C.; Fujita, M.; Tsuyoshi, H.; Yoshida, Y. Chronic low-grade inflammation and ovarian dysfunction in women with polycystic ovarian syndrome, endometriosis, and aging. Front. Endocrinol. 2023, 14, 1324429. [Google Scholar] [CrossRef] [PubMed]
- Gupta, S.; Agarwal, A.; Krajcir, N.; Alvarez, J.G. Role of oxidative stress in endometriosis. Reprod. Biomed. Online 2006, 13, 126–134. [Google Scholar] [CrossRef]
- Mu, F.; Harris, H.R.; Rich-Edwards, J.W.; Hankinson, S.E.; Rimm, E.B.; Spiegelman, D.; Missmer, S.A. A Prospective Study of Inflammatory Markers and Risk of Endometriosis. Am. J. Epidemiol. 2018, 187, 515–522. [Google Scholar] [CrossRef]
- Xie, C.; Lu, C.; Lv, N.; Kong, W.; Liu, Y. Identification and analysis of oxidative stress-related genes in endometriosis. Front. Immunol. 2025, 16, 1515490. [Google Scholar] [CrossRef]
- García-Gómez, E.; Vázquez-Martínez, E.R.; Reyes-Mayoral, C.; Cruz-Orozco, O.P.; Camacho-Arroyo, I.; Cerbón, M. Regulation of Inflammation Pathways and Inflammasome by Sex Steroid Hormones in Endometriosis. Front. Endocrinol. 2020, 10, 935. [Google Scholar] [CrossRef] [PubMed]
- Huang, F.; Cao, J.; Liu, Q.; Zou, Y.; Li, H.; Yin, T. MAPK/ERK signal pathway involved expression of COX-2 and VEGF by IL-1β induced in human endometriosis stromal cells in vitro. Int. J. Clin. Exp. Pathol. 2013, 6, 2129–2136. [Google Scholar]
- Lai, Z.Z.; Yang, H.L.; Ha, S.Y.; Chang, K.K.; Mei, J.; Zhou, W.J.; Qiu, X.M.; Wang, X.Q.; Zhu, R.; Li, D.J.; et al. Cyclooxygenase-2 in Endometriosis. Int. J. Biol. Sci. 2019, 15, 2783–2797. [Google Scholar] [CrossRef]
- Kim, M.E.; Lee, J.S. Advances in the Regulation of Inflammatory Mediators in Nitric Oxide Synthase: Implications for Disease Modulation and Therapeutic Approaches. Int. J. Mol. Sci. 2025, 26, 1204. [Google Scholar] [CrossRef]
- Yeo, S.G.; Oh, Y.J.; Lee, J.M.; Yeo, J.H.; Kim, S.S.; Park, D.C. Production and Role of Nitric Oxide in Endometrial Cancer. Antioxidants 2025, 14, 369. [Google Scholar] [CrossRef]
- Yeo, S.G.; Oh, Y.J.; Lee, J.M.; Kim, S.S.; Park, D.C. A Narrative Review of the Expression and Role of Nitric Oxide in Endometriosis. Antioxidants 2025, 14, 247. [Google Scholar] [CrossRef]
- Krygere, L.; Jukna, P.; Jariene, K.; Drejeriene, E. Diagnostic Potential of Cytokine Biomarkers in Endometriosis: Challenges and Insights. Biomedicines 2024, 12, 2867. [Google Scholar] [CrossRef] [PubMed]
- Fan, Y.-Y.; Chen, H.-Y.; Chen, W.; Liu, Y.-N.; Fu, Y.; Wang, L.-N. Expression of inflammatory cytokines in serum and peritoneal fluid from patients with different stages of endometriosis. Gynecol. Endocrinol. 2018, 34, 507–512. [Google Scholar] [CrossRef] [PubMed]
- Park, W.; Lim, W.; Kim, M.; Jang, H.; Park, S.J.; Song, G.; Park, S. Female reproductive disease, endometriosis: From inflammation to infertility. Mol. Cells 2025, 48, 100164. [Google Scholar] [CrossRef] [PubMed]
- Dai, Y.; Ye, Z.; Lin, X.; Zhang, S. Immunopathological insights into endometriosis: From research advances to future treatments. Semin. Immunopathol. 2025, 47, 31. [Google Scholar] [CrossRef]
- Abramiuk, M.; Grywalska, E.; Małkowska, P.; Sierawska, O.; Hrynkiewicz, R.; Niedźwiedzka-Rystwej, P. The Role of the Immune System in the Development of Endometriosis. Cells 2022, 11, 2028. [Google Scholar] [CrossRef]
- Kasoha, M.; Sklavounos, P.; Molnar, I.; Nigdelis, M.P.; Haj Hamoud, B.; Solomayer, E.-F.; Klamminger, G.G. Evaluation of inflammatory serum parameters as a diagnostic tool in patients with endometriosis: A case-control study. Sci. Rep. 2025, 15, 20172. [Google Scholar] [CrossRef]
- Zdrojkowski, Ł.; Jasiński, T.; Ferreira-Dias, G.; Pawliński, B.; Domino, M. The Role of NF-κB in Endometrial Diseases in Humans and Animals: A Review. Int. J. Mol. Sci. 2023, 24, 2901. [Google Scholar] [CrossRef]
- González-Ramos, R.; Van Langendonckt, A.; Defrère, S.; Lousse, J.-C.; Colette, S.; Devoto, L.; Donnez, J. Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis. Fertil. Steril. 2010, 94, 1985–1994. [Google Scholar] [CrossRef]
- Banerjee, S.; Xu, W.; Doctor, A.; Driss, A.; Nezhat, C.; Sidell, N.; Taylor, R.N.; Thompson, W.E.; Chowdhury, I. TNFα-Induced Altered miRNA Expression Links to NF-κB Signaling Pathway in Endometriosis. Inflammation 2023, 46, 2055–2070. [Google Scholar] [CrossRef] [PubMed]
- Barbe, A.M.; Berbets, A.M.; Davydenko, I.S.; Koval, H.D.; Yuzko, V.O.; Yuzko, O.M. Expression and Significance of Matrix Metalloproteinase-2 and Matrix Metalloproteinas-9 in Endometriosis. J. Med. Life 2020, 13, 314–320. [Google Scholar] [CrossRef] [PubMed]
- Ke, J.; Ye, J.; Li, M.; Zhu, Z. The Role of Matrix Metalloproteinases in Endometriosis: A Potential Target. Biomolecules 2021, 11, 1739. [Google Scholar] [CrossRef] [PubMed]
- Xu, X.; Li, J.; Lin, H.; Lin, Z.; Ji, G. The role of TGF-β superfamily in endometriosis: A systematic review. Front. Immunol. 2025, 16, 1638604. [Google Scholar] [CrossRef]
- Adamyan, L.; Pivazyan, L.; Murvatova, K.; Tarlakyan, V.; Zarova, E.; Stepanian, A.; Mailova, K. Association between the level of TGF- β expression and endometriosis: A systematic review and meta-analysis. J. Endometr. Uterine Disord. 2025, 9, 100100. [Google Scholar] [CrossRef]
- Siampalis, A.; Papakonstantinou, E.; Keramida, M.; Panteris, E.; Kalogeropoulos, S.; Georgopoulos, N.; Taniguchi, F.; Adonakis, G.; Harada, T.; Kaponis, A. The effect of combined oral contraceptive pills on angiogenesis in endometriotic lesions. Hormones 2025, 24, 517–524. [Google Scholar] [CrossRef]
- Yu, K.; Huang, Z.-Y.; Xu, X.-L.; Li, J.; Fu, X.-W.; Deng, S.-L. Estrogen Receptor Function: Impact on the Human Endometrium. Front. Endocrinol. 2022, 13, 827724. [Google Scholar] [CrossRef]
- Chantalat, E.; Valera, M.-C.; Vaysse, C.; Noirrit, E.; Rusidze, M.; Weyl, A.; Vergriete, K.; Buscail, E.; Lluel, P.; Fontaine, C.; et al. Estrogen Receptors and Endometriosis. Int. J. Mol. Sci. 2020, 21, 2815. [Google Scholar] [CrossRef] [PubMed]
- Mori, T.; Ito, F.; Koshiba, A.; Kataoka, H.; Takaoka, O.; Okimura, H.; Khan, K.N.; Kitawaki, J. Local estrogen formation and its regulation in endometriosis. Reprod. Med. Biol. 2019, 18, 305–311. [Google Scholar] [CrossRef]
- Gou, Y.; Li, X.; Li, P.; Zhang, H.; Xu, T.; Wang, H.; Wang, B.; Ma, X.; Jiang, X.; Zhang, Z. Estrogen receptor β upregulates CCL2 via NF-κB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis. Hum. Reprod. 2019, 34, 646–658. [Google Scholar] [CrossRef] [PubMed]
- de Araújo, F.F.; de Paulo Farias, D.; Neri-Numa, I.A.; Pastore, G.M. Polyphenols and their applications: An approach in food chemistry and innovation potential. Food Chem. 2021, 338, 127535. [Google Scholar] [CrossRef]
- Lang, Y.; Gao, N.; Zang, Z.; Meng, X.; Lin, Y.; Yang, S.; Yang, Y.; Jin, Z.; Li, B. Classification and antioxidant assays of polyphenols: A review. J. Future Foods 2024, 4, 193–204. [Google Scholar] [CrossRef]
- Bolat, E.; Sarıtaş, S.; Duman, H.; Eker, F.; Akdaşçi, E.; Karav, S.; Witkowska, A.M. Polyphenols: Secondary Metabolites with a Biological Impression. Nutrients 2024, 16, 2550. [Google Scholar] [CrossRef]
- Tassinari, V.; Smeriglio, A.; Stillittano, V.; Trombetta, D.; Zilli, R.; Tassinari, R.; Maranghi, F.; Frank, G.; Marcoccia, D.; Di Renzo, L. Endometriosis Treatment: Role of Natural Polyphenols as Anti-Inflammatory Agents. Nutrients 2023, 15, 2967. [Google Scholar] [CrossRef]
- Zieniuk, B.; Uğur, Ş. The Therapeutic Potential of Baicalin and Baicalein in Breast Cancer: A Systematic Review of Mechanisms and Efficacy. Curr. Issues Mol. Biol. 2025, 47, 181. [Google Scholar] [CrossRef]
- Liu, H.; Dong, Y.; Gao, Y.; Du, Z.; Wang, Y.; Cheng, P.; Chen, A.; Huang, H. The Fascinating Effects of Baicalein on Cancer: A Review. Int. J. Mol. Sci. 2016, 17, 1681. [Google Scholar] [CrossRef] [PubMed]
- Ke, J.-Y.; Yang, J.; Li, J.; Xu, Z.; Li, M.-Q.; Zhu, Z.-L. Baicalein inhibits FURIN-MT1-MMP-mediated invasion of ectopic endometrial stromal cells in endometriosis possibly by reducing the secretion of TGFB1. Am. J. Reprod. Immunol. 2021, 85, e13344. [Google Scholar] [CrossRef] [PubMed]
- Szymczak, J.; Cielecka-Piontek, J. Fisetin—In Search of Better Bioavailability—From Macro to Nano Modifications: A Review. Int. J. Mol. Sci. 2023, 24, 14158. [Google Scholar] [CrossRef] [PubMed]
- Zhou, C.; Huang, Y.; Nie, S.; Zhou, S.; Gao, X.; Chen, G. Biological effects and mechanisms of fisetin in cancer: A promising anti-cancer agent. Eur. J. Med. Res. 2023, 28, 297. [Google Scholar] [CrossRef]
- Kumar, R.M.; Kumar, H.; Bhatt, T.; Jain, R.; Panchal, K.; Chaurasiya, A.; Jain, V. Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics. Pharmaceuticals 2023, 16, 196. [Google Scholar] [CrossRef]
- Hassan, S.S.u.; Samanta, S.; Dash, R.; Karpiński, T.M.; Habibi, E.; Sadiq, A.; Ahmadi, A.; Bungau, S. The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress. Front. Pharmacol. 2022, 13, 1015835. [Google Scholar] [CrossRef]
- Arangia, A.; Marino, Y.; Fusco, R.; Siracusa, R.; Cordaro, M.; D’Amico, R.; Macrì, F.; Raffone, E.; Impellizzeri, D.; Cuzzocrea, S.; et al. Fisetin, a Natural Polyphenol, Ameliorates Endometriosis Modulating Mast Cells Derived NLRP-3 Inflammasome Pathway and Oxidative Stress. Int. J. Mol. Sci. 2023, 24, 5076. [Google Scholar] [CrossRef]
- Vollmannová, A.; Bojňanská, T.; Musilová, J.; Lidiková, J.; Cifrová, M. Quercetin as one of the most abundant represented biological valuable plant components with remarkable chemoprotective effects—A review. Heliyon 2024, 10, e33342. [Google Scholar] [CrossRef] [PubMed]
- Aghababaei, F.; Hadidi, M. Recent Advances in Potential Health Benefits of Quercetin. Pharmaceuticals 2023, 16, 1020. [Google Scholar] [CrossRef]
- Alharbi, H.O.A.; Alshebremi, M.; Babiker, A.Y.; Rahmani, A.H. The Role of Quercetin, a Flavonoid in the Management of Pathogenesis Through Regulation of Oxidative Stress, Inflammation, and Biological Activities. Biomolecules 2025, 15, 151. [Google Scholar] [CrossRef] [PubMed]
- Delenko, J.; Xue, X.; Chatterjee, P.K.; Hyman, N.; Shih, A.J.; Adelson, R.P.; Safaric Tepes, P.; Gregersen, P.K.; Metz, C.N. Quercetin enhances decidualization through AKT-ERK-p53 signaling and supports a role for senescence in endometriosis. Reprod. Biol. Endocrinol. 2024, 22, 100. [Google Scholar] [CrossRef]
- Shahbaz, M.; Imran, M.; Momal, U.; Naeem, H.; Alsagaby, S.A.; Al Abdulmonem, W.; El-Ghorab, A.H.; Ghoneim, M.M.; Hussain, M.; Shaker, M.E.; et al. Potential effect of kaempferol against various malignancies: Recent advances and perspectives. Food Agric. Immunol. 2023, 34, 2265690. [Google Scholar] [CrossRef]
- Jin, S.; Zhang, L.; Wang, L. Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine. Biomed. Pharmacother. 2023, 165, 115215. [Google Scholar] [CrossRef] [PubMed]
- Chuwa, A.H.; Sone, K.; Oda, K.; Tanikawa, M.; Kukita, A.; Kojima, M.; Oki, S.; Fukuda, T.; Takeuchi, M.; Miyasaka, A.; et al. Kaempferol, a natural dietary flavonoid, suppresses 17β-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer. Oncol. Lett. 2018, 16, 6195–6201. [Google Scholar] [CrossRef]
- Song, X.; Tan, L.; Wang, M.; Ren, C.; Guo, C.; Yang, B.; Ren, Y.; Cao, Z.; Li, Y.; Pei, J. Myricetin: A review of the most recent research. Biomed. Pharmacother. 2021, 134, 111017. [Google Scholar] [CrossRef]
- Semwal, D.K.; Semwal, R.B.; Combrinck, S.; Viljoen, A. Myricetin: A Dietary Molecule with Diverse Biological Activities. Nutrients 2016, 8, 90. [Google Scholar] [CrossRef] [PubMed]
- Imran, M.; Saeed, F.; Hussain, G.; Imran, A.; Mehmood, Z.; Gondal, T.A.; El-Ghorab, A.; Ahmad, I.; Pezzani, R.; Arshad, M.U.; et al. Myricetin: A comprehensive review on its biological potentials. Food Sci. Nutr. 2021, 9, 5854–5868. [Google Scholar] [CrossRef]
- Park, S.; Song, G.; Lim, W. Myricetin inhibits endometriosis growth through cyclin E1 down-regulation in vitro and in vivo. J. Nutr. Biochem. 2020, 78, 108328. [Google Scholar] [CrossRef]
- Kciuk, M.; Alam, M.; Ali, N.; Rashid, S.; Głowacka, P.; Sundaraj, R.; Celik, I.; Yahya, E.B.; Dubey, A.; Zerroug, E.; et al. Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications. Molecules 2023, 28, 5246. [Google Scholar] [CrossRef]
- Dai, W.; Ruan, C.; Zhang, Y.; Wang, J.; Han, J.; Shao, Z.; Sun, Y.; Liang, J. Bioavailability enhancement of EGCG by structural modification and nano-delivery: A review. J. Funct. Foods 2020, 65, 103732. [Google Scholar] [CrossRef]
- Capasso, L.; De Masi, L.; Sirignano, C.; Maresca, V.; Basile, A.; Nebbioso, A.; Rigano, D.; Bontempo, P. Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential. Molecules 2025, 30, 654. [Google Scholar] [CrossRef] [PubMed]
- Mokra, D.; Adamcakova, J.; Mokry, J. Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases? Antioxidants 2022, 11, 1566. [Google Scholar] [CrossRef]
- Laschke, M.W.; Schwender, C.; Scheuer, C.; Vollmar, B.; Menger, M.D. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Hum. Reprod. 2008, 23, 2308–2318. [Google Scholar] [CrossRef] [PubMed]
- Di, M.; Zhang, Q.; Wang, J.; Xiao, X.; Huang, J.; Ma, Y.; Yang, H.; Li, M. Epigallocatechin-3-gallate (EGCG) attenuates inflammatory responses and oxidative stress in lipopolysaccharide (LPS)-induced endometritis via silent information regulator transcript-1 (SIRT1)/nucleotide oligomerization domain (NOD)-like receptor pyrin domain-containing 3 (NLRP3) pathway. J. Biochem. Mol. Toxicol. 2022, 36, e23203. [Google Scholar] [CrossRef]
- Salehi, B.; Venditti, A.; Sharifi-Rad, M.; Kręgiel, D.; Sharifi-Rad, J.; Durazzo, A.; Lucarini, M.; Santini, A.; Souto, E.B.; Novellino, E.; et al. The Therapeutic Potential of Apigenin. Int. J. Mol. Sci. 2019, 20, 1305. [Google Scholar] [CrossRef]
- Glinkowska, A.; Rzepecka-Stojko, A.; Stojko, J. Therapeutic Potential of Flavonoids—The Use of Apigenin in Medicine. Appl. Sci. 2025, 15, 12996. [Google Scholar] [CrossRef]
- Rosiak, N.; Tykarska, E.; Miklaszewski, A.; Pietrzak, R.; Cielecka-Piontek, J. Enhancing the Solubility and Dissolution of Apigenin: Solid Dispersions Approach. Int. J. Mol. Sci. 2025, 26, 566. [Google Scholar] [CrossRef]
- Liang, Y.-C.; Zhong, Q.; Ma, R.-H.; Ni, Z.-J.; Thakur, K.; Khan, M.R.; Busquets, R.; Zhang, J.-G.; Wei, Z.-J. Apigenin inhibits migration and induces apoptosis of human endometrial carcinoma Ishikawa cells via PI3K-AKT-GSK-3β pathway and endoplasmic reticulum stress. J. Funct. Foods 2022, 94, 105116. [Google Scholar] [CrossRef]
- Imran, M.; Rauf, A.; Abu-Izneid, T.; Nadeem, M.; Shariati, M.A.; Khan, I.A.; Imran, A.; Orhan, I.E.; Rizwan, M.; Atif, M.; et al. Luteolin, a flavonoid, as an anticancer agent: A review. Biomed. Pharmacother. 2019, 112, 108612. [Google Scholar] [CrossRef]
- Vithalkar, M.P.; Beere, V.; Sandra, K.S.; Naik, V.; Dessai, A.D.; Nayak, U.Y.; Fayaz, S.M.; Andugulapati, S.B.; Sathyanarayana, B.; Nagareddy, P.R.; et al. Luteolin as a multi-targeted polyphenol in pulmonary fibrosis: Network pharmacology, mechanistic insights, and formulation advances. Beni-Suef Univ. J. Basic Appl. Sci. 2025, 14, 96. [Google Scholar] [CrossRef]
- Lv, J.; Song, X.; Luo, Z.; Huang, D.; Xiao, L.; Zou, K. Luteolin: Exploring its therapeutic potential and molecular mechanisms in pulmonary diseases. Front. Pharmacol. 2025, 16, 1535555. [Google Scholar] [CrossRef] [PubMed]
- Mahwish; Imran, M.; Naeem, H.; Hussain, M.; Alsagaby, S.A.; Al Abdulmonem, W.; Mujtaba, A.; Abdelgawad, M.A.; Ghoneim, M.M.; El-Ghorab, A.H.; et al. Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies. Food Sci. Nutr. 2025, 13, e4682. [Google Scholar] [CrossRef] [PubMed]
- Park, S.; Lim, W.; You, S.; Song, G. Ameliorative effects of luteolin against endometriosis progression in vitro and in vivo. J. Nutr. Biochem. 2019, 67, 161–172. [Google Scholar] [CrossRef]
- Andrabi, S.A.; Spina, M.G.; Lorenz, P.; Ebmeyer, U.; Wolf, G.; Horn, T.F. Oxyresveratrol (trans-2,3′,4,5′-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia. Brain Res. 2004, 1017, 98–107. [Google Scholar] [CrossRef]
- Puranik, N.; Kumari, M.; Tiwari, S.; Dhakal, T.; Song, M. Resveratrol as a Therapeutic Agent in Alzheimer’s Disease: Evidence from Clinical Studies. Nutrients 2025, 17, 2557. [Google Scholar] [CrossRef] [PubMed]
- Salehi, B.; Mishra, A.P.; Nigam, M.; Sener, B.; Kilic, M.; Sharifi-Rad, M.; Fokou, P.V.T.; Martins, N.; Sharifi-Rad, J. Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines 2018, 6, 91. [Google Scholar] [CrossRef] [PubMed]
- Malaguarnera, L. Influence of Resveratrol on the Immune Response. Nutrients 2019, 11, 946. [Google Scholar] [CrossRef]
- Gołąbek-Grenda, A.; Juzwa, W.; Kaczmarek, M.; Olejnik, A. Resveratrol and Its Natural Analogs Mitigate Immune Dysregulation and Oxidative Imbalance in the Endometriosis Niche Simulated in a Co-Culture System of Endometriotic Cells and Macrophages. Nutrients 2024, 16, 3483. [Google Scholar] [CrossRef]
- Chen, Z.; Wang, C.; Lin, C.; Zhang, L.; Zheng, H.; Zhou, Y.; Li, X.; Li, C.; Zhang, X.; Yang, X.; et al. Lipidomic Alterations and PPARα Activation Induced by Resveratrol Lead to Reduction in Lesion Size in Endometriosis Models. Oxidative Med. Cell. Longev. 2021, 2021, 9979953. [Google Scholar] [CrossRef]
- Arablou, T.; Aryaeian, N.; Khodaverdi, S.; Kolahdouz-Mohammadi, R.; Moradi, Z.; Rashidi, N.; Delbandi, A.-A. The effects of resveratrol on the expression of VEGF, TGF-β, and MMP-9 in endometrial stromal cells of women with endometriosis. Sci. Rep. 2021, 11, 6054. [Google Scholar] [CrossRef]
- Nouri, Z.; Fakhri, S.; Nouri, K.; Wallace, C.E.; Farzaei, M.H.; Bishayee, A. Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach. Cancers 2020, 12, 2276. [Google Scholar] [CrossRef] [PubMed]
- Choi, S.-S.; Park, H.-R.; Lee, K.-A. A Comparative Study of Rutin and Rutin Glycoside: Antioxidant Activity, Anti-Inflammatory Effect, Effect on Platelet Aggregation and Blood Coagulation. Antioxidants 2021, 10, 1696. [Google Scholar] [CrossRef]
- Caparica, R.; Júlio, A.; Araújo, M.E.M.; Baby, A.R.; Fonte, P.; Costa, J.G.; Santos de Almeida, T. Anticancer Activity of Rutin and Its Combination with Ionic Liquids on Renal Cells. Biomolecules 2020, 10, 233. [Google Scholar] [CrossRef]
- Sun, X.-Y.; Li, L.-J.; Dong, Q.-X.; Zhu, J.; Huang, Y.-R.; Hou, S.-J.; Yu, X.-L.; Liu, R.-T. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease. J. Neuroinflamm. 2021, 18, 131. [Google Scholar] [CrossRef]
- Rahmani, S.; Naraki, K.; Roohbakhsh, A.; Hayes, A.W.; Karimi, G. The protective effects of rutin on the liver, kidneys, and heart by counteracting organ toxicity caused by synthetic and natural compounds. Food Sci. Nutr. 2023, 11, 39–56. [Google Scholar] [CrossRef] [PubMed]
- Talebi, H.; Farahpour, M.R.; Hamishehkar, H. The effectiveness of Rutin for prevention of surgical induced endometriosis development in a rat model. Sci. Rep. 2021, 11, 7180. [Google Scholar] [CrossRef]
- Chen, C.; Wang, C.; Jiang, H.; Wang, M.; Rahman, S.U.; Chen, C.; Ding, H.; Zhao, C.; Huang, W.; Wang, X. Rutin Alleviates Zearalenone-Induced Endoplasmic Reticulum Stress and Mitochondrial Pathway Apoptosis in Porcine Endometrial Stromal Cells by Promoting the Expression of Nrf2. Toxins 2025, 17, 7. [Google Scholar] [CrossRef] [PubMed]
- Ahmed, M.; Bose, I.; Goksen, G.; Roy, S. Himalayan Sources of Anthocyanins and Its Multifunctional Applications: A Review. Foods 2023, 12, 2203. [Google Scholar] [CrossRef] [PubMed]
- Tarone, A.G.; Cazarin, C.B.B.; Marostica Junior, M.R. Anthocyanins: New techniques and challenges in microencapsulation. Food Res. Int. 2020, 133, 109092. [Google Scholar] [CrossRef]
- Jiang, D.-Q.; Guo, Y.; Xu, D.-H.; Huang, Y.-S.; Yuan, K.; Lv, Z.-Q. Antioxidant and anti-fatigue effects of anthocyanins of mulberry juice purification (MJP) and mulberry marc purification (MMP) from different varieties mulberry fruit in China. Food Chem. Toxicol. 2013, 59, 1–7. [Google Scholar] [CrossRef]
- Park, S.; Lim, W.; Song, G. Delphinidin induces antiproliferation and apoptosis of endometrial cells by regulating cytosolic calcium levels and mitochondrial membrane potential depolarization. J. Cell. Biochem. 2019, 120, 5072–5084. [Google Scholar] [CrossRef]
- Liu, Y.-N.; Hu, X.-J.; Liu, B.; Shang, Y.-J.; Xu, W.-T.; Zhou, H.-F. Network Pharmacology-Based Prediction of Bioactive Compounds and Potential Targets of Wenjing Decoction for Treatment of Endometriosis. Evid.-Based Complement. Altern. Med. 2021, 2021, 4521843. [Google Scholar] [CrossRef]
- Zhang, L.; Mohankumar, K.; Martin, G.; Mariyam, F.; Park, Y.; Han, S.J.; Safe, S. Flavonoids Quercetin and Kaempferol Are NR4A1 Antagonists and Suppress Endometriosis in Female Mice. Endocrinology 2023, 164, bqad133. [Google Scholar] [CrossRef]
- Cao, Y.; Zhuang, M.-F.; Yang, Y.; Xie, S.-W.; Cui, J.-G.; Cao, L.; Zhang, T.-T.; Zhu, Y. Preliminary Study of Quercetin Affecting the Hypothalamic-Pituitary-Gonadal Axis on Rat Endometriosis Model. Evid.-Based Complement. Altern. Med. 2014, 2014, 781684. [Google Scholar] [CrossRef] [PubMed]
- Li, X.; Zhu, Q.; Ma, M.; Guo, H. Quercetin inhibits the progression of endometrial HEC-1-A cells by regulating ferroptosis—A preliminary study. Eur. J. Med. Res. 2022, 27, 292. [Google Scholar] [CrossRef] [PubMed]
- Wang, C.; Chen, Z.; Zhao, X.; Lin, C.; Hong, S.; Lou, Y.; Shi, X.; Zhao, M.; Yang, X.; Guan, M.-X.; et al. Transcriptome-Based Analysis Reveals Therapeutic Effects of Resveratrol on Endometriosis in aRat Model. Drug Des. Dev. Ther. 2021, 15, 4141–4155. [Google Scholar] [CrossRef]
- Taguchi, A.; Wada-Hiraike, O.; Kawana, K.; Koga, K.; Yamashita, A.; Shirane, A.; Urata, Y.; Kozuma, S.; Osuga, Y.; Fujii, T. Resveratrol suppresses inflammatory responses in endometrial stromal cells derived from endometriosis: A possible role of the sirtuin 1 pathway. J. Obstet. Gynaecol. Res. 2014, 40, 770–778. [Google Scholar] [CrossRef] [PubMed]
- Gołąbek-Grenda, A.; Kaczmarek, M.; Juzwa, W.; Olejnik, A. Natural resveratrol analogs differentially target endometriotic cells into apoptosis pathways. Sci. Rep. 2023, 13, 11468. [Google Scholar] [CrossRef]
- Zheng, C.; Wang, Y.; Bi, B.; Zhou, W.; Cao, X.; Zhang, C.; Lu, W.; Sun, Y.; Qu, J.; Lv, W. Gallic acid ameliorates endometrial hyperplasia through the inhibition of the PI3K/AKT pathway and the down-regulation of cyclin D1 expression. J. Pharmacol. Sci. 2024, 155, 1–13. [Google Scholar] [CrossRef]
- Jamali, N.; Mostafavi-Pour, Z.; Zal, F.; Kasraeian, M.; Poordast, T.; Nejabat, N. Antioxidant ameliorative effect of caffeic acid on the ectopic endometrial cells separated from patients with endometriosis. Taiwan. J. Obstet. Gynecol. 2021, 60, 216–220. [Google Scholar] [CrossRef]
- Wang, Y.; Zhang, S. Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2. Biomed. Pharmacother. 2018, 103, 1287–1293. [Google Scholar] [CrossRef]
- Liang, X.; Wang, Y.; Li, T.; Li, P.; Jiang, G. Mechanistic Study on the Alleviation of Endometritis in Mice Through Inhibition of NF-κB and MAPK Signaling Pathways by Berberine and Carvacrol. Microorganisms 2025, 13, 1051. [Google Scholar] [CrossRef]
- Park, Y.; Cho, Y.J.; Sung, N.; Park, M.J.; Guan, X.; Gibbons, W.E.; O’Malley, B.W.; Han, S.J. Oleuropein suppresses endometriosis progression and improves the fertility of mice with endometriosis. J. Biomed. Sci. 2022, 29, 100. [Google Scholar] [CrossRef] [PubMed]
- Warowicka, A.; Qasem, B.; Dera-Szymanowska, A.; Wołuń-Cholewa, M.; Florczak, P.; Horst, N.; Napierała, M.; Szymanowski, K.; Popenda, Ł.; Bartkowiak, G.; et al. Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression. Pharmaceutics 2021, 13, 931. [Google Scholar] [CrossRef]
- He, S.; Li, H.; Wan, L.; Qin, X. Global landscape of clinical trials for endometriosis: Dynamic trends and future directions. Int. J. Surg. 2025, 111, 7355–7358. [Google Scholar] [CrossRef] [PubMed]
- Maia, H., Jr.; Haddad, C.; Pinheiro, N.; Casoy, J. Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain. Int. J. Womens Health 2012, 4, 543–549. [Google Scholar] [CrossRef]
- Signorile, P.G.; Viceconte, R.; Baldi, A. Novel dietary supplement association reduces symptoms in endometriosis patients. J. Cell. Physiol. 2018, 233, 5920–5925. [Google Scholar] [CrossRef] [PubMed]
- Rostami, S.; Alyasin, A.; Saedi, M.; Nekoonam, S.; Khodarahmian, M.; Moeini, A.; Amidi, F. Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial. Front. Endocrinol. 2023, 14, 1144323. [Google Scholar] [CrossRef]
- Meneghetti, J.K.; Pedrotti, M.T.; Coimbra, I.M.; da Cunha-Filho, J.S.L. Effect of Dietary Interventions on Endometriosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Reprod. Sci. 2024, 31, 3613–3623. [Google Scholar] [CrossRef]
- Barrea, L.; Verde, L.; Annunziata, G.; Chedraui, P.; Petraglia, F.; Cucalón, G.; Camajani, E.; Caprio, M.; Gorini, S.; Iorio, G.G.; et al. Effectiveness of Medical Nutrition Therapy in the Management of Patients with Obesity and Endometriosis: From the Mediterranean Diet To the Ketogenic Diet, Through Supplementation. The Role of the Nutritionist in Clinical Management. Curr. Obes. Rep. 2025, 14, 68. [Google Scholar] [CrossRef]
- Dikshit, A.; Sarkar, R.; Pradhan, B.; Segoni, S.; Alamri, A.M. Rainfall Induced Landslide Studies in Indian Himalayan Region: A Critical Review. Appl. Sci. 2020, 10, 2466. [Google Scholar] [CrossRef]
- Aryal, K.P.; Poudel, S.; Chaudhary, R.P.; Chettri, N.; Chaudhary, P.; Ning, W.; Kotru, R. Diversity and use of wild and non-cultivated edible plants in the Western Himalaya. J. Ethnobiol. Ethnomed. 2018, 14, 10. [Google Scholar] [CrossRef]
- Chauhan, J.S.; Gautam, A.S.; Negi, R.S. Natural and Anthropogenic Impacts on Forest Structure: A Case Study of Uttarakhand State. Open Environ. Res. J. 2018, 11, TOERJ–11–38. [Google Scholar] [CrossRef]
- Sharma, P.; Chettri, N.; Wangchuk, K. Human–wildlife conflict in the roof of the world: Understanding multidimensional perspectives through a systematic review. Ecol. Evol. 2021, 11, 11569–11586. [Google Scholar] [CrossRef] [PubMed]
- Bachheti, A.; Deepti; Bachheti, R.K.; Singh, A.; Zebeaman, M.; Hunde, Y.; Husen, A. Bioactive constituents and health promoting compounds of underutilized fruits of the northern Himalayas of India: A review. Food Prod. Process. Nutr. 2023, 5, 24. [Google Scholar] [CrossRef]
- Cheema, J.; Yadav, K.; Sharma, N.; Saini, I.; Aggarwal, A. Nutritional Quality Characteristics of Different Wild and Underutilized Fruits of Terai Region, Uttarakhand (India). Int. J. Fruit Sci. 2017, 17, 72–81. [Google Scholar] [CrossRef]
- Bhatt, S.C.; Kumar, V.; Gupta, A.K.; Mishra, S.; Naik, B.; Rustagi, S.; Preet, M.S. Insights on bio-functional properties of Myrica esculenta plant for nutritional and livelihood security. Food Chem. Adv. 2023, 3, 100434. [Google Scholar] [CrossRef]
- Shrivastava, A.K.; Chaudhary, D.; Shrestha, L.; Awadalla, M.E.; Al-Shouli, S.T.; Palikhey, A.; Eltayb, W.A.; Gupta, A.; Gupta, P.P.; Parab, M.; et al. GC-MS Based Metabolite Profiling, and Anti-Inflammatory Activity of Aqueous Extract of Myrica esculenta through In Vitro and In Silico Approach. Med. Sci. Forum 2023, 21, 52. [Google Scholar]
- Rodrigues, E.L.; Marcelino, G.; Silva, G.T.; Figueiredo, P.S.; Garcez, W.S.; Corsino, J.; Guimarães, R.d.C.A.; Freitas, K.d.C. Nutraceutical and Medicinal Potential of the Morus Species in Metabolic Dysfunctions. Int. J. Mol. Sci. 2019, 20, 301. [Google Scholar] [CrossRef]
- Belwal, T.; Pandey, A.; Bhatt, I.D.; Rawal, R.S.; Luo, Z. Trends of polyphenolics and anthocyanins accumulation along ripening stages of wild edible fruits of Indian Himalayan region. Sci. Rep. 2019, 9, 5894. [Google Scholar] [CrossRef] [PubMed]
- Janiak, M.A.; Gryn-Rynko, A.; Sulewska, K.; Amarowicz, R.; Penkacik, K.; Graczyk, R.; Olszewska-Słonina, D.; Majewski, M.S. Phenolic profiles and antioxidant activity of Morus alba L. infusions prepared from commercially available products and naturally collected leaves. Sci. Rep. 2025, 15, 13030. [Google Scholar] [CrossRef]
- Lamichhane, A.; Lamichhane, G.; Devkota, H.P. Yellow Himalayan Raspberry (Rubus ellipticus Sm.): Ethnomedicinal, Nutraceutical, and Pharmacological Aspects. Molecules 2023, 28, 6071. [Google Scholar] [CrossRef]
- Kumari, A.; Prakash, V.; Gupta, D.; Kashyap, L.; Goyal, R.; Chopra, H.; Gautam, R.K.; Chakraborty, S.; Chandran, D.; Dhama, K. Identification and evaluation of antimicrobial and anti-arthritis activities of hydroethanolic extract of Rubus ellipticus leaves. Narra J. 2023, 3, e152. [Google Scholar] [CrossRef]
- Neag, M.A.; Mocan, A.; Echeverría, J.; Pop, R.M.; Bocsan, C.I.; Crişan, G.; Buzoianu, A.D. Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders. Front. Pharmacol. 2018, 9, 557. [Google Scholar] [CrossRef]
- Huneif, M.A.; Alqahtani, S.M.; Abdulwahab, A.; Almedhesh, S.A.; Mahnashi, M.H.; Riaz, M.; Ur-Rahman, N.; Jan, M.S.; Ullah, F.; Aasim, M.; et al. α-Glucosidase, α-Amylase and Antioxidant Evaluations of Isolated Bioactives from Wild Strawberry. Molecules 2022, 27, 3444. [Google Scholar] [CrossRef]
- Sharma, I.P.; Kanta, C.; Semwal, S.C.; Goswami, N. Wild Fruits of Uttarakhand (India): Ethnobotanical and Medicinal Uses. Int. J. Complement. Altern. Med. 2017, 8, 00260. [Google Scholar] [CrossRef]
- Song, S.; Li, J.; Liu, H.; Qi, Y.; Subbiah, V.; Sharifi-Rad, J.; Setzer, W.N.; Suleria, H.A.R. Pyracantha as a promising functional food: A comprehensive review on bioactive characteristics, pharmacological activity, and industrial applications. Food Front. 2023, 4, 1720–1736. [Google Scholar] [CrossRef]
- Dhyani, D.; Maikhuri, R.K.; Dhyani, S. Seabuckthorn: An Underutilized Resource for the Nutritional Security and Livelihood Improvement of Rural Communities in Uttarakhand Himalaya. Ecol. Food Nutr. 2011, 50, 168–180. [Google Scholar] [CrossRef]
- Rymbai, H.; Verma, V.K.; Talang, H.; Assumi, S.R.; Devi, M.B.; Vanlalruati; Sangma, R.H.C.; Biam, K.P.; Chanu, L.J.; Makdoh, B.; et al. Biochemical and antioxidant activity of wild edible fruits of the eastern Himalaya, India. Front. Nutr. 2023, 10, 1039965. [Google Scholar] [CrossRef]
- Mishra, A.; Swamy, S.L.; Thakur, T.K.; Bhat, R.; Bijalwan, A.; Kumar, A. Use of Wild Edible Plants: Can They Meet the Dietary and Nutritional Needs of Indigenous Communities in Central India. Foods 2021, 10, 1453. [Google Scholar] [CrossRef] [PubMed]
- Thakur, D.; Sharma, A.; Uniyal, S.K. Why they eat, what they eat: Patterns of wild edible plants consumption in a tribal area of Western Himalaya. J. Ethnobiol. Ethnomed. 2017, 13, 70. [Google Scholar] [CrossRef] [PubMed]
- de la Rosa, L.A.; Moreno-Escamilla, J.O.; Rodrigo-García, J.; Alvarez-Parrilla, E. Chapter 12—Phenolic Compounds. In Postharvest Physiology and Biochemistry of Fruits and Vegetables; Yahia, E.M., Ed.; Woodhead Publishing: Cambridge, UK, 2019; pp. 253–271. [Google Scholar]
- Meena, V.S.; Gora, J.S.; Singh, A.; Ram, C.; Meena, N.K.; Pratibha; Rouphael, Y.; Basile, B.; Kumar, P. Underutilized Fruit Crops of Indian Arid and Semi-Arid Regions: Importance, Conservation and Utilization Strategies. Horticulturae 2022, 8, 171. [Google Scholar] [CrossRef]
- Marappan, K.; Sadasivam, S.; Natarajan, N.; Arumugam, V.A.; Lakshmaiah, K.; Thangaraj, M.; Giridhar Gopal, M.; Asokan, A. Underutilized fruit crops as a sustainable approach to enhancing nutritional security and promoting economic growth. Front. Sustain. Food Syst. 2025, 9, 1618112. [Google Scholar] [CrossRef]
- Donno, D.; Mellano, M.G.; Cerutti, A.K.; Beccaro, G.L. Nutraceuticals in alternative and underutilized fruits as functional food ingredients: Ancient species for new health needs. In Alternative and Replacement Foods; Elsevier: Amsterdam, The Netherlands, 2018; pp. 261–282. [Google Scholar]
- Zhang, Z.; Li, X.; Sang, S.; McClements, D.J.; Chen, L.; Long, J.; Jiao, A.; Jin, Z.; Qiu, C. Polyphenols as Plant-Based Nutraceuticals: Health Effects, Encapsulation, Nano-Delivery, and Application. Foods 2022, 11, 2189. [Google Scholar] [CrossRef]
- Yadav, S.; Nair, N.; Biharee, A.; Prathap, V.M.; Majeed, J. Updated ethnobotanical notes, phytochemistry and phytopharmacology of plants belonging to the genus Morus (Family: Moraceae). Phytomed. Plus 2022, 2, 100120. [Google Scholar] [CrossRef]
- Kumar, V.; Sharma, A.; Sharma, N.; Saini, R.; Dev, K.; El-Shazly, M.; Bari, A.B.A. A review of botany, traditional applications, phytochemistry, pharmacological applications, and toxicology of Rubus ellipticus Smith fruits. Naunyn-Schmiedeb. Arch. Pharmacol. 2024, 397, 4483–4497. [Google Scholar] [CrossRef]
- Yang, C.-X.; Liu, S.-Y.; Zerega, N.J.C.; Stull, G.W.; Gardner, E.M.; Tian, Q.; Gu, W.; Lu, Q.; Folk, R.A.; Kates, H.R.; et al. Phylogeny and Biogeography of Morus (Moraceae). Agronomy 2023, 13, 2021. [Google Scholar] [CrossRef]
- Porasar, P.; Gibo, R.; Gogoi, B.; Sharma, D.; Bharadwaj, A.; Gam, S.; Hazarika, D.; Dutta, K.N. A Systematic review on the phytochemistry, isolated compounds, nutritional benefits, pharmacology and toxicology of the plant species Morus alba L. Discov. Plants 2025, 2, 7. [Google Scholar] [CrossRef]
- Cásedas, G.; Moliner, C.; Abad-Longas, A.; Núñez, S.; Gómez-Rincón, C.; Maggi, F.; López, V. Black Mulberries (Morus nigra L.) Modulate Oxidative Stress and Beta-Amyloid-Induced Toxicity, Becoming a Potential Neuroprotective Functional Food. Foods 2024, 13, 2577. [Google Scholar] [CrossRef]
- Özgür, M.; Uçar, A.; Yılmaz, S. The multifaceted benefits of Morus nigra L.: A pharmacological powerhouse. Phytochem. Rev. 2025, 24, 5317–5342. [Google Scholar] [CrossRef]
- Ferraz, A.P.C.R.; Figueiredo, P.d.O.; Yoshida, N.C. Black Mulberry (Morus nigra L.): A Review of Attributes as an Anticancer Agent to Encourage Pharmaceutical Development. Adv. Pharmacol. Pharm. Sci. 2024, 2024, 3784092. [Google Scholar] [CrossRef]
- Zhang, H.; Ma, Z.F.; Luo, X.; Li, X. Effects of Mulberry Fruit (Morus alba L.) Consumption on Health Outcomes: A Mini-Review. Antioxidants 2018, 7, 69. [Google Scholar] [CrossRef]
- Fatima, M.; Dar, M.A.; Dhanavade, M.J.; Abbas, S.Z.; Bukhari, M.N.; Arsalan, A.; Liao, Y.; Wan, J.; Shah Syed Bukhari, J.; Ouyang, Z. Biosynthesis and Pharmacological Activities of the Bioactive Compounds of White Mulberry (Morus alba): Current Paradigms and Future Challenges. Biology 2024, 13, 506. [Google Scholar] [CrossRef]
- Hu, Z.; Su, Y.; Jia, J.; Bian, X.; Gu, Y.; Lv, G.; Chen, S.; Jiang, N. Mulberry—Nutritional Value, Health Benefits, and its Applications in Food, Biomaterials, and Medicine: A Systematic Review with Bibliometric Analysis. Nat. Prod. Commun. 2025, 20, 1934578X251314698. [Google Scholar] [CrossRef]
- Belwal, T.; Bisht, A.; Devkota, H.P.; Ullah, H.; Khan, H.; Pandey, A.; Bhatt, I.D.; Echeverría, J. Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases. Front. Pharmacol. 2020, 11, 41. [Google Scholar] [CrossRef]
- Hansda, P.; Kumar, S.; Garkoti, S.C. Differential rhizosphere soil nutrient use strategy of invasive and native shrub species in oak, pine, and oak-pine mixed forest ecosystems of the Himalaya. Rhizosphere 2025, 33, 101021. [Google Scholar] [CrossRef]
- Bhardwaj, D.; Kaushik, N. Phytochemical and pharmacological studies in genus Berberis. Phytochem. Rev. 2012, 11, 523–542. [Google Scholar] [CrossRef]
- Srivastava, S.; Srivastava, M.; Misra, A.; Pandey, G.; Rawat, A. A review on biological and chemical diversity in Berberis (Berberidaceae). EXCLI J. 2015, 14, 247–267. [Google Scholar] [CrossRef] [PubMed]
- Fan, Z.; Wei, X.; Zhu, X.; Yang, K.; Tian, L.; Wang, X.; Du, Y.; Yang, L. Unveiling the therapeutic potential of berberine: Its therapeutic role and molecular mechanisms in kidney diseases. Front. Pharmacol. 2025, 16, 1549462. [Google Scholar] [CrossRef] [PubMed]
- Fatima Hashmi, S.; Saleem, H.; Khurshid, U.; Khursheed, A.; Tauquir Alam, M.; Imran, M.; Abida; Nayeem, N.; Shoaib Ali Gill, M. Genus Berberis: A Comprehensive and Updated Review on Ethnobotanical Uses, Phytochemistry and Pharmacological Activities. Chem. Biodivers. 2024, 21, e202400911. [Google Scholar] [CrossRef]
- Jain, S.; Tripathi, S.; Tripathi, P.K. Antioxidant and antiarthritic potential of berberine: In vitro and in vivo studies. Chin. Herb. Med. 2023, 15, 549–555. [Google Scholar] [CrossRef]
- Pliszko, A.; Wójcik, T.; Kostrakiewicz-Gierałt, K. Phytosociological and Abiotic Factors Influencing the Coverage and Morphological Traits of the Invasive Alien Potentilla indica (Rosaceae) in Riparian Forests and Other Urban Habitats: A Case Study from Kraków, Southern Poland. Forests 2024, 15, 2229. [Google Scholar] [CrossRef]
- Saavedra-Molina, A.; Lemus-de la Cruz, J.; Landa-Moreno, C.; Murillo-Villicaña, M.; García-Berumen, C.; Montoya-Pérez, R.; Manzo Avalos, S.; Aguilera-Méndez, A.; Salgado-Garciglia, R.; Cortés-Rojo, C. Antioxidant Activity of Natural Products from Medicinal Plants. In The Power of Antioxidants-Unleashing Nature’s Defense Against Oxidative Stress; IntechOpen: London, UK, 2024. [Google Scholar]
- Landa-Moreno, C.I.; Trejo-Hurtado, C.M.; Lemus-de la Cruz, J.; Pena-Montes, D.J.; Murillo-Villicana, M.; Huerta-Cervantes, M.; Montoya-Perez, R.; Salgado-Garciglia, R.; Manzo-Avalos, S.; Cortes-Rojo, C.; et al. Antioxidant Effect of the Ethyl Acetate Extract of Potentilla indica on Kidney Mitochondria of Streptozotocin-Induced Diabetic Rats. Plants 2023, 12, 3196. [Google Scholar] [CrossRef]
- Augustynowicz, D.; Lemieszek, M.K.; Strawa, J.W.; Wiater, A.; Tomczyk, M. Anticancer potential of acetone extracts from selected Potentilla species against human colorectal cancer cells. Front. Pharmacol. 2022, 13, 1027315. [Google Scholar] [CrossRef]
- Joshi, Y.; Joshi, A.K.; Prasad, N.; Juyal, D. A review on Ficus palmata (wild himalayan fig). J. Phytopharm. 2014, 3, 374–377. [Google Scholar] [CrossRef]
- Phondani, P.C.; Maikhuri, R.K.; Rawat, L.S.; Negi, V.S. Assessing farmers’ perception on criteria and indicators for sustainable management of indigenous agroforestry systems in Uttarakhand, India. Environ. Sustain. Indic. 2020, 5, 100018. [Google Scholar] [CrossRef]
- Shi, Y.; Mon, A.M.; Fu, Y.; Zhang, Y.; Wang, C.; Yang, X.; Wang, Y. The genus Ficus (Moraceae) used in diet: Its plant diversity, distribution, traditional uses and ethnopharmacological importance. J. Ethnopharmacol. 2018, 226, 185–196. [Google Scholar] [CrossRef]
- Tewari, D.; Gupta, P.; Bawari, S.; Sah, A.N.; Barreca, D.; Khayatkashani, M.; Khayat Kashani, H.R. Himalayan Ficus palmata L. Fruit Extract Showed In Vivo Central and Peripheral Analgesic Activity Involving COX-2 and Mu Opioid Receptors. Plants 2021, 10, 1685. [Google Scholar] [CrossRef] [PubMed]
- Tewari, D.; Zengin, G.; Ak, G.; Sinan, K.I.; Cziáky, Z.; Mishra, S.T.; Jekő, J. Phenolic Profiling, Antioxidants, Multivariate, and Enzyme Inhibitory Properties of Wild Himalayan Fig (Ficus palmata Forssk.): A Potential Candidate for Designing Innovative Nutraceuticals and Related Products. Anal. Lett. 2021, 54, 1439–1456. [Google Scholar] [CrossRef]
- Saklani, S.; Chandra, S. Phytochemical screening of garhwal himalaya wild edible fruit Ficus palmata. Int. J. Pharm. Tech. Res. 2012, 4, 1185–1191. [Google Scholar]
- Kumari, K.; Sharma, S.; Joshi, V.; Sharma, S. Adding value to wild Himalayan fig (Ficus palmata): Composition, functional and sensory characteristics of jam. J. Phytopharmacol. 2018, 7, 13–18. [Google Scholar] [CrossRef]
- Hussain, A.; Yasar, M.; Ahmad, G.; Ijaz, M.; Aziz, A.; Nawaz, M.G.; Khan, F.A.; Iqbal, H.; Shakeel, W.; Momand, H.; et al. Synthesis, characterization, and applications of iron oxide nanoparticles. Int. J. Health Sci. 2023, 17, 3–10. [Google Scholar]
- Sharma, R.; Raghuvanshi, R.; Kumar, R.; Thakur, M.S.; Kumar, S.; Patel, M.K.; Chaurasia, O.P.; Saxena, S. Current findings and future prospective of high-value trans Himalayan medicinal plant Lycium ruthenicum Murr: A systematic review. Clin. Phytosci. 2022, 8, 3. [Google Scholar] [CrossRef]
- Solomando González, J.C.; Rodríguez Gómez, M.J.; Ramos García, M.; Nicolás Barroso, N.; Calvo Magro, P. Characterization and Selection of Lycium barbarum Cultivars Based on Physicochemical, Bioactive, and Aromatic Properties. Horticulturae 2025, 11, 924. [Google Scholar] [CrossRef]
- Liu, J.; Xu, D.; Chen, S.; Yuan, F.; Mao, L.; Gao, Y. Superfruits in China: Bioactive phytochemicals and their potential health benefits—A Review. Food Sci. Nutr. 2021, 9, 6892–6902. [Google Scholar] [CrossRef] [PubMed]
- Ilić, T.; Krgović, N.; Čakar, U.; Kodranov, I.; Milenković, M.; Vidović, B. Phytochemical Properties, Antioxidant Capacity, and Hypoglycemic Potential of Goji Berry Juice from Serbia. Horticulturae 2025, 11, 1308. [Google Scholar] [CrossRef]
- Sicari, V.; Romeo, R.; Mincione, A.; Santacaterina, S.; Tundis, R.; Loizzo, M.R. Ciabatta Bread Incorporating Goji (Lycium barbarum L.): A New Potential Functional Product with Impact on Human Health. Foods 2023, 12, 566. [Google Scholar] [CrossRef]
- Skenderidis, P.; Leontopoulos, S.; Lampakis, D. Goji Berry: Health Promoting Properties. Nutraceuticals 2022, 2, 32–48. [Google Scholar] [CrossRef]
- Wen, P.; Hu, T.-G.; Linhardt, R.J.; Liao, S.-T.; Wu, H.; Zou, Y.-X. Mulberry: A review of bioactive compounds and advanced processing technology. Trends Food Sci. Technol. 2019, 83, 138–158. [Google Scholar] [CrossRef]
- Sharma, P.; Negi, R.S.; Malik, S.; Patil, U.K.; Thareja, S. An Overview of Phytochemistry and Ethnopharmacological Aspects of Myrica esculenta. N. Z. J. Crop Hortic. Sci. 2026, 54, e70086. [Google Scholar] [CrossRef]
- Singh, S.P.; Tiyasha, T.; Negi, N.; Bhagat, S.K.; Kumar, V. Integrated review of Myrica esculenta (bayberry) in therapeutic nutritional and environmental contexts. Discov. Food 2025, 5, 253. [Google Scholar] [CrossRef]
- Ngurthankhumi, R.; Hazarika, T.K.; Lalruatsangi, E.; Lalnunsangi, T.; Lalhmangaihzuali, H.P. Bioactive constituents and health promoting compounds of few wild edible fruits of North-East India. Int. J. Food Prop. 2024, 27, 927–950. [Google Scholar] [CrossRef]
- Sawian, C.E.; Susngi, A.M.; Manners, B.; Sawian, J.T. Myrica esculenta. In Himalayan Fruits and Berries; Belwal, T., Bhatt, I., Devkota, H., Eds.; Academic Press: Cambridge, MA, USA, 2023; pp. 287–303. [Google Scholar]
- Kaviani, B.; Deltalab, B.; Kulus, D.; Tymoszuk, A.; Bagheri, H.; Azarinejad, T. In Vitro Propagation of Pyracantha angustifolia (Franch.) C.K. Schneid. Horticulturae 2022, 8, 964. [Google Scholar] [CrossRef]
- Negi, G.C.S. Trees, forests and people: The Central Himalayan case of forest ecosystem services. Trees For. People 2022, 8, 100222. [Google Scholar] [CrossRef]
- Singh, S.; Mehta, J.P.; Singh, B. Exploring botanical varieties in alpine landscape of Himalayas: A study of vegetation and species composition in Madhmaheshwar Valley, Western Himalaya, India. Trees For. People 2024, 18, 100672. [Google Scholar] [CrossRef]
- Jaiswal, J.; Upadhyaya, K.; Arya, V. Pyracantha crenulata: A Review of Its Botanical Features, Ecological Significance, And Horticultural Potential. Int. J. Pharm. Sci. 2024, 2, 1387–1396. [Google Scholar] [CrossRef]
- Gupta, S.; Jasrotia, S.; Kandwal, A.; Rawat, R.; Purohit, M. Green synthesis of silver nitrate nanoparticles using L. of Pyracantha crenulata and its anticancer activity on liver cancer. J. Mt. Res. 2023, 18, 273–283. [Google Scholar] [CrossRef]
- Kewlani, P.; Tiwari, D.; Rawat, S.; Bhatt, I.D. Pharmacological and phytochemical potential of Rubus ellipticus: A wild edible with multiple health benefits. J. Pharm. Pharmacol. 2023, 75, 143–161. [Google Scholar] [CrossRef]
- Dangwal, L.R.; Bhujabal, B.; Lal, T.; Rawat, M.; Shukla, U.K.; Panwar, A. Ethnobotanical survey of lesser-known economic plants in the Chamba region of the Western Himalaya, Uttarakhand, India. Ethnobot. Res. Appl. 2025, 30, 1–21. [Google Scholar] [CrossRef]
- Vo, T.P.; Pham, T.V.; Weina, K.; Tran, T.N.H.; Vo, L.T.V.; Nguyen, P.T.; Bui, T.L.H.; Phan, T.H.; Nguyen, D.Q. Green extraction of phenolics and flavonoids from black mulberry fruit using natural deep eutectic solvents: Optimization and surface morphology. BMC Chem. 2023, 17, 119. [Google Scholar] [CrossRef] [PubMed]
- Narra, F.; Piragine, E.; Benedetti, G.; Ceccanti, C.; Florio, M.; Spezzini, J.; Troisi, F.; Giovannoni, R.; Martelli, A.; Guidi, L. Impact of thermal processing on polyphenols, carotenoids, glucosinolates, and ascorbic acid in fruit and vegetables and their cardiovascular benefits. Compr. Rev. Food Sci. Food Saf. 2024, 23, e13426. [Google Scholar] [CrossRef] [PubMed]
- Sendri, N.; Bhandari, P. Polyphenolic composition and antioxidant potential of underutilized Himalayan wild edible berries by high-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight mass spectrometry. J. Sep. Sci. 2021, 44, 4237–4254. [Google Scholar] [CrossRef] [PubMed]



| Compound | Experimental System | Molecular Mechanism of Action | Significant Results | Reference |
|---|---|---|---|---|
| Quercetin and kaemferol | Luciferase-expressing FVB female mice and primary human endometrial stromal cells | Modulation of NR4A1-mediated cellular pathways | Decreased Luciferase activity of ectopic lesions at 100 mg/kg/day. Inhibited mTOR. Decreased fibrosis progression. | [125] |
| Quercitin | Female SD rats | Modulation in the HPGA axis | Decrease in the level of FSH and LH. Downregulation of ERα and PR in the endometrium. | [126] |
| HEC-1-A cells | Inducing ferroptosis in HEC-1-A cells | Inhibition of proliferation at 104.2 μM at 24 h | [127] | |
| Resveratrol | Female SD rats | Migitating the activation of PPARγ (Peroxisome proliferator-activated receptor gamma) | Decreased lesion size, alteration in macrophage polarisation, glucose tolerance, and adipocyte size | [128] |
| Endometriotic stromal cells | Activation of Sirtuin 1 | Suppressed expression of IL-8 in endometriotic stromal cells. | [129] | |
| Human endometrial stromal cells | Increase in the expression of the antiapoptotic BCL2 gene | Pterostilbene inhibited the proliferation of cells. Resveratrol and its analogs increased the number of apoptotic cells. | [130] | |
| Gallic acid | Female C57BL/6 mice and Human Endometrial Epithelial Cells. | Downregulation of cyclin D1 expression of PI3K/AKT pathway genes | Gallic acid inhibited endometrial epithelial cell proliferation. Alleviates endometrial hyperplasia | [131] |
| Caffeic acid | Ectopic endometrial cells | Increase in Nrf-2 gene expression, indicating a possible modulation via Nrf-2/HO-1/NQO1 pathway | Downregulated ROS levels, HO-1 and NQO1 activity. | [132] |
| Berberine | AN3 CA and HEC-1-A Endometrial cancer cells | Modulation in miR-101/COX-2 axis | Repressed migration and inhibited invasion potential of cells in cell lines | [133] |
| Berberine and Carvacol | Female Kunming mice | Inhibition of NF-κB and MAPK pathway activation | Downregulated the mRNA expression of TLR2 and TLR4. Inhibition of phosphorylation of NF-κB and MAPK signaling pathway proteins. Downregulation of TNF-α, IL-1β, IL-6, and IL-8 expression. | [134] |
| Oleuropein | C57BL/6J, luciferase-expressing FVB, FVB, and SCID female mice and HeLa cells | Suppression of the TNFα-induced phosphorylation of Akt and p44/p42 MAP kinase | Selective inhibition of Erβ activity in HeLa cells at 10 nM. Suppressed progression of ectopic lesions in SCID mice. Upregulated the levels of the cleaved form of caspase 3, reactivating apoptosis in epithelial and stromal cells of ectopic lesions. | [135] |
| Protoberberine (coptisine, berberine, sanguinarine, and stylopine) | Female Wistar rats | Upregulation of the concentration of metabolites involved in energy homeostasis, including glucose, lactate, and glutamate | Ectopic lesions were decreased. | [136] |
| Fruits | Common Name | Traditional Uses | Bioactive Compounds Identified | Parts | References |
|---|---|---|---|---|---|
| Myrica esculenta | Kaphal, kaiphal, katphal, and kataphal | Jaundice, fever, bronchitis, dysentery, body ache, headache, ulcer | Proanthocyanins, alkaloids, tannins, glycosides, gallic acid, hexadecanol, ascorbic acids, cis-β-caryophyllene, n-octadecanol, phytosterols, saponins, catechin, chlorogenic acid, trans-cinnamic acid, p-coumaric acid, hydroxybenzoic acid, gallic acid, caffeic acid, methyl salicylate, O-amino benzohydroxamic acid, pyridine, and ellagic acid. | Stem, leaves, and fruit | [149,150] |
| Morus nigra and Morus alba | Shahtoot | Prevention of various diseases of the liver, kidney, and aging | Tannins, coumarins, triterpene, anthocyanins (cyanidin and delphinidin), catechin, chlorogenic acid, and 3-hydroxybenzoic acid, 4-hydroxybenzoic acid, vanillic acid, rutin, quercetin-3-O-glucoside, ascorbic acid, resveratrol, β-carotene, gallic acid, and fatty acid (palmitic acid, linolic acid, and oleic acid). | Leaves, fruits | [151,152,153] |
| Rubus ellipticus | Hisaul, hisalu | Mature fruits are used in the treatment of coughs and fever, and roots and shoots are well known for their renal tonic, anti-diuretic, and diarrhoea, dysentery | β-carotene, anthocyanins (cyanidin and delphinidin), ascorbic acid, rutin, caffeic acid, gallic acid, m-coumaric acid, chlorogenic acid, 3-hydroxybenzoic acid, 4-hydroxybenzoic acid, ferulic acid, ellagic acid, phloridzin, and vanillic acid. | Leaves, roots, shoots, and fruit | [152,154,155] |
| Berberis asiatica | Kingor, Chutro, rasanjan (Nep); marpyashi (Newa); daruharidra, darbi (Sans) | Jaundice, diabetes mellitus, wound healing, asthma; drying unhealthy ulcers, anti-inflammatory, swelling, treating pneumococcal infections, eye (conjunctivitis) and ear diseases, rheumatism, fever, stomach disorders, skin disease (hyperpigmentation), malarial fever | Carotenoids (α and β-carotene), ascorbic acid, anthocyanins, gallic acid, catechin, caffeic acid, chlorogenic acid, and coumaric acid | Roots, shoot, stem, bark, and fruit | [152,156] |
| Potentilla indica | False strawberry | Leprosy, tissue inflammation, congenital fever, cancer, and diabetes mellitus | Sterols, volatile oils, ellagitannins, ellagic acid and its derivatives, hydroxybenzoic acid, and hydroxycinnamic acid, brevifolin carboxylate, caffeic acid, acarbose, ascorbic acid, 2,4-dichloro-6-hydroxy-3,5-dimethoxytoluene, and 2-methyl-6-(4-methylphenyl)-2-hepten-4-one. | Whole plant | [120,157] |
| Pyracantha crenulata | Ghigharu | Cardioprotective, anti-hypertensive, antioxidants, reduction in cholesterol, anti-malarial | Ascorbic acid, β-carotene, lycopene, catechin, anthocyanins (cyanidin and delphinidin), gallic acid, phloridzin, ferulic acid, chlorogenic acid, 3-hydroxybenzoic acid, 4-hydroxybenzoic acid, caffeic acid, m-coumaric acid, p-coumaric acid, ellagic acid, and condensed tannins | Stem, bark, leaf | [152,158,159] |
| Product | Ingredients | Dosage | Target | Manufactured by |
|---|---|---|---|---|
| HealthyHey grape seed extract | Grape seed extract | 500 mg | Antioxidant activity | HealthyHey Foods LLP, Mumbai, India |
| Green tea leaf extract | Green tea leaf extract, Piper nigrum extract | 650 mg | Anti-inflammatory, anti-aging, weight-mediating | MyFitFuel, Inventiva Labs Pvt Ltd., Delhi, India |
| Now Foods, natural resveratrol | Polygonum cuspidatum extract complex, grape seed extract | 200 mg | Cardiovascular support, anti-ageing, anti-inflammatory | Now Foods, USA |
| Quercetin with Bromelain health capsules | Quercetin, bromelain | 1200 mg | Antioxidant, anti-inflammatory | SAS India PVT LTD |
| Resveratrol complex | Japanese knotweed extract, grape seeds, red wine, blueberry, grape skin | 1800 mg | Antioxidant | Piping Rock Health Products, USA |
| Polyphenol complex | A blend of pomegranate, citrus bioflavonoids, grape seed, resveratrol, apple peel, blueberry, cranberry, strawberry, acerola, acai, turmeric, broccoli seed, green tea, quercetin, olive leaf, and ginkgo leaf extracts. | 2250 mg | Antioxidant | UBNA distribution LLC, USA |
| Apple polyphenols | Apple extract standardised to 80% polyphenols and 5% phloridzin | 600 mg | Antioxidant, cardioprotective, weight and cholesterol lowering, and oral health management, | Super smart, USA |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Khantwal, G.; Panthari, P.; Saini, R.K. Polyphenol-Rich Wild Fruits of the Indian Himalayas as a Potential Nutraceutical Candidate for the Management of Endometriosis: A Review. Foods 2026, 15, 1178. https://doi.org/10.3390/foods15071178
Khantwal G, Panthari P, Saini RK. Polyphenol-Rich Wild Fruits of the Indian Himalayas as a Potential Nutraceutical Candidate for the Management of Endometriosis: A Review. Foods. 2026; 15(7):1178. https://doi.org/10.3390/foods15071178
Chicago/Turabian StyleKhantwal, Garima, Pooja Panthari, and Ramesh Kumar Saini. 2026. "Polyphenol-Rich Wild Fruits of the Indian Himalayas as a Potential Nutraceutical Candidate for the Management of Endometriosis: A Review" Foods 15, no. 7: 1178. https://doi.org/10.3390/foods15071178
APA StyleKhantwal, G., Panthari, P., & Saini, R. K. (2026). Polyphenol-Rich Wild Fruits of the Indian Himalayas as a Potential Nutraceutical Candidate for the Management of Endometriosis: A Review. Foods, 15(7), 1178. https://doi.org/10.3390/foods15071178

